Uncategorized

Our history

The Sativa Group PLC and Stillcanna Inc merged to create Sativa Wellness Group Inc., a company whose overall CBD and wellness opportunities in Europe should be unrivalled. The history of the companies prior to the merger can be given if you contact [email protected]. All news and announcements given on this website are running up to the merger and since the merger to create the Sativa Wellness Group Inc.

Latest Updates

ANNOUNCEMENT: Proposed Financing and Dispute Settlement

Sativa Wellness Group is pleased to announce that it intends to complete a non-brokered private placement financing (the “Financing”) of units (each, a “Unit”) for gross proceeds of up to CDN$4,000,000 with a price per Unit of CDN$0.07875.

Each Unit will consist of one common share (each, a “Share”) and one half of one common share purchase warrant (each, a “Warrant”), with each Warrant exercisable to acquire one additional Share (each, a “Warrant Share”) for a period of 24 months following the closing date of the Financing (the “Closing Date’). The Warrants shall have an exercise price of CDN$0.105 per Warrant Share. The Warrants are not subject to any acceleration clause.

ANNOUNCEMENT: Launch of 8 more COVID Testing Facilities

Sativa Wellness Group is pleased to announce that our Bath and Bristol Goodbody clinics booked up to £27,000 a day in COVID testing revenues in December. Having proved the testing model in Bath and Bristol, we have rolled out a number of in-pharmacy clinics and today we open our tenth testing facility with a further twenty in-pharmacy clinics in process.

ANNOUNCEMENT: Novel Food Application

Sativa Wellness Group is pleased to announce that it has submitted its Novel Food application for validation by the Food Standards Agency (“FSA”) ahead of the 31 March 2021 deadline, as part of the Company’s ongoing commitment to continually deliver the highest level of regulatory compliance and product quality – ‘CBD you can trust’.

ANNOUNCEMENT: Sativa Wellness Group Announces Further Board Update

Further to the Company’s news release dated January 29, 2021 regarding the Annual General and Special Meeting of the shareholders held on January 26, 2021 (the “Meeting”), each of Geremy Thomas and George Thomas have been appointed as directors, and Geremy Thomas has been appointed as Executive Chairman of the Board.

ANNOUNCEMENT: Sativa Wellness Provides Business Update

Although the world is still in the grip of the global COVID pandemic, the Company has held steadfast in our commitment to building a long-term growth company in the European CBD and wellness space. Our commitment to producing and distributing the highest quality and compliant products and services to the market also remains.

ANNOUNCEMENT: December Record Sales

Sativa Wellness (AQSE and CSE: SWEL) notes today’s announcement by the Aquis Stock Exchange PLC, that the two new segments of the market have come into force. Please see Aquis Stock Exchange link for the full announcement.

Sativa Wellness has been notified by AQSE that it qualifies for the “Apex” segment of the AQSE Growth Market. In order to be eligible for admission to Apex, Sativa has succeeded in meeting, amongst other things, the following specific criteria…

ANNOUNCEMENT: SATIVA QUALIFIES FOR NEW APEX MARKET SEGMENT

Sativa Wellness (AQSE and CSE: SWEL) notes today’s announcement by the Aquis Stock Exchange PLC, that the two new segments of the market have come into force. Please see Aquis Stock Exchange link for the full announcement.

Sativa Wellness has been notified by AQSE that it qualifies for the “Apex” segment of the AQSE Growth Market. In order to be eligible for admission to Apex, Sativa has succeeded in meeting, amongst other things, the following specific criteria…

ANNOUNCEMENT: CBD and Cannabis Regulatory Progress from The United Nations, European Commission and US House of Representatives

“Sativa Wellness welcomes the clarity that these regulatory updates bring to the CBD wellness and medicinal cannabis industry in Europe, the US and globally. We believe that a well-regulated cannabis sector will lead to consumers benefitting from safe, compliant and quality products, such as our Goodbody CBD brands, and opens the pathway for patients to benefit from further research into the efficacy of medicinal cannabis…

ANNOUNCEMENT: Sativa Wellness Announces Corporate Update

We are pleased to announce that the board of directors have resolved to change the Company’s fiscal year end from July 31 to December 31, effective immediately.

By moving the Company’s reporting cycle to a calendar quarter basis in line with the operating subsidiaries of the Company, Sativa Wellness aims to reduce the time constraints and administrative expenses with having to reconcile multiple reporting periods among other related corporations.

ANNOUNCEMENT: Sativa Wellness Expands COVID Testing Clinic in Store to Bristol

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 30 September 2020, being the last business day prior to the date of this announcement, it had 302,592,941 common shares of no par value each in issue and admitted to trading on the AQSE Growth Market. Sativa Wellness holds no common shares in treasury…

ANNOUNCEMENT: EU courts clear the way for CBD in Europe

The European Union’s highest court has ruled that CBD (Cannabidiol) is not a narcotic drug, and that a French ban on hemp derived CBD contradicts EU law. This ruling has opened the door for high quality compliant CBD companies to operate in markets across the EU. The Sativa Wellness Group Inc. welcomes this news as the company operates CBD extraction and production facilities in the UK and Europe…